Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zai Lab Ltd ADR (ZLAB)

Zai Lab Ltd ADR (ZLAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Zai Lab Ltd ADR 899 Halei Road Building B Pudong Shanghai F4 201203 CHN

www.zailaboratory.com Employees: 1,869 P: 86-21-6163-2588

Sector:

Medical

Description:

Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China.

Key Statistics

Overview:

Market Capitalization, $K 1,975,027
Enterprise Value, $K 1,557,067
Shares Outstanding, K 111,963
Annual Sales, $ 398,990 K
Annual Net Income, $ -257,100 K
Last Quarter Sales, $ 116,100 K
Last Quarter Net Income, $ -35,960 K
EBIT, $ -227,920 K
EBITDA, $ -219,580 K
60-Month Beta 0.87
% of Insider Shareholders 4.96%
% of Institutional Shareholders 41.65%
Float, K 106,410
% Float 95.04%
Short Interest 5,301
Short Float 4.73%
Short Volume Ratio 0.42

Growth:

1-Year Return -33.36%
3-Year Return -61.93%
5-Year Return -87.90%
5-Year Revenue Growth 2,971.52%
5-Year Earnings Growth 14.19%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.33 on 11/06/25
Next Earnings Date 02/26/26
Earnings Per Share ttm -1.95
EPS Growth vs. Prev Qtr 10.81%
EPS Growth vs. Prev Year 21.43%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ZLAB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -25.82%
Return-on-Assets % -17.67%
Profit Margin % -64.44%
Debt/Equity 0.27
Price/Sales 4.95
Price/Cash Flow N/A
Price/Book 2.59
Book Value/Share 6.80
Interest Coverage -113.27
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar